33 related articles for article (PubMed ID: 34600897)
1. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
Rendle KA; Saia CA; Vachani A; Burnett-Hartman AN; Doria-Rose VP; Beucker S; Neslund-Dudas C; Oshiro C; Kim RY; Elston-Lafata J; Honda SA; Ritzwoller D; Wainwright JV; Mitra N; Greenlee RT
Ann Intern Med; 2024 Jan; 177(1):18-28. PubMed ID: 38163370
[TBL] [Abstract][Full Text] [Related]
2. Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes : A Pre-Post Study With a Control Group.
Garabedian LF; Zhang F; Costa R; Argetsinger S; Ross-Degnan D; Wharam JF
Ann Intern Med; 2024 Apr; 177(4):439-448. PubMed ID: 38527286
[TBL] [Abstract][Full Text] [Related]
3. A predictive model for lung cancer screening nonadherence in a community setting health-care network.
Bastani M; Chiuzan C; Silvestri G; Raoof S; Chusid J; Diefenbach M; Cohen SL
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 37027213
[TBL] [Abstract][Full Text] [Related]
4. Health Care Utilization and Costs in Lung Cancer Screening Participants-A Propensity-Matched Economic Analysis.
Tremblay A; Premji S; Thanh NX; Yang H; MacEachern P; Penz E; Cressman S; Bedard ELR
JTO Clin Res Rep; 2023 Dec; 4(12):100594. PubMed ID: 38074772
[TBL] [Abstract][Full Text] [Related]
5. Demographics and socioeconomic determinants of health predict continued participation in a CT lung cancer screening program.
Wang Z; Kim Y; Mortani Barbosa EJ
Curr Probl Diagn Radiol; 2024 Apr; ():. PubMed ID: 38658287
[TBL] [Abstract][Full Text] [Related]
6. Biopsy frequency and complications among lung cancer patients in the United States.
Zhang Y; Shi L; Simoff MJ; J Wagner O; Lavin J
Lung Cancer Manag; 2020 Aug; 9(4):LMT40. PubMed ID: 33318758
[TBL] [Abstract][Full Text] [Related]
7. Downstream Complications From Lung Cancer Screening Higher Than Thought.
Harris E
JAMA; 2024 Feb; 331(5):385. PubMed ID: 38231488
[No Abstract] [Full Text] [Related]
8. Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.
Miller SJ; Sly JR; Rolfo C; Mack P; Villanueva A; Mazor M; Weber E; Lin JJ; Smith CB; Taioli E
Health Aff Sch; 2024 May; 2(5):qxae039. PubMed ID: 38783890
[TBL] [Abstract][Full Text] [Related]
9. Social Determinants of Health in Imaging-based Cancer Screening: A Case-based Primer with Strategies for Care Improvement.
Abraham P; Haddad A; Bishay AE; Bishay S; Sonubi C; Jaramillo-Cardoso A; Sava M; Yee J; Flores EJ; Spalluto LB
Radiographics; 2023 Nov; 43(11):e230008. PubMed ID: 37824411
[TBL] [Abstract][Full Text] [Related]
10. Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial.
Lin MY; Liu T; Gatsonis C; Sicks JD; Shih S; Carlos RC; Gareen IF
J Am Coll Radiol; 2023 Oct; 20(10):1022-1030. PubMed ID: 37423348
[TBL] [Abstract][Full Text] [Related]
11. Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.
Lemieux ME; Reveles XT; Rebeles J; Bederka LH; Araujo PR; Sanchez JR; Grayson M; Lai SC; DePalo LR; Habib SA; Hill DG; Lopez K; Patriquin L; Sussman R; Joyce RP; Rebel VI
Respir Res; 2023 Jan; 24(1):23. PubMed ID: 36681813
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
13. Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care.
Tailor TD; Bell S; Fendrick AM; Carlos RC
J Am Coll Radiol; 2022 Jan; 19(1 Pt A):35-46. PubMed ID: 34600897
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Downstream Procedures on Lung Cancer Screening Adherence.
Tailor TD; Bell S; Carlos RC
J Am Coll Radiol; 2023 Oct; 20(10):969-978. PubMed ID: 37586471
[TBL] [Abstract][Full Text] [Related]
15. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
16. Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.
Tailor TD; Bell S; Doo FX; Carlos RC
J Am Coll Radiol; 2023 Jan; 20(1):29-36. PubMed ID: 36436778
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
